Synthetic and Systems Biotechnology, published by KEAI PUBLISHING LTD, is a pioneering open-access journal that has made significant contributions to the fields of applied microbiology, biotechnology, biomedical engineering, genetics, and structural biology since its inception in 2016. With an ISSN of 2405-805X, this journal is committed to fostering innovative research and interdisciplinary collaboration, providing a platform for the dissemination of high-quality studies that push the boundaries of scientific knowledge. Recognized for its excellence, it holds prestigious Q1 rankings in both Applied Microbiology and Biotechnology as well as Biomedical Engineering in 2023, alongside notable Q2 rankings in Genetics and Structural Biology. Researchers, professionals, and students alike can access cutting-edge research that explores the dynamic interplay between synthetic biology and systems biology, driving advancements that could reshape health, industry, and environmental sustainability. By operating under an open-access model, Synthetic and Systems Biotechnology ensures that new findings are accessible to a global audience, thereby maximizing the impact and reach of the published work and paving the way for future discoveries.

Research Journal of Biotechnology is a premier publication dedicated to advancing the field of biotechnology through the dissemination of impactful research articles. Published by Research Journal Biotechnology in India, this journal operates under an Open Access model, facilitating unrestricted access to high-quality research for researchers, professionals, and students worldwide. With an ISSN of 2278-4535 and an E-ISSN of 2278-4535, the journal aims to serve as a comprehensive platform for innovative studies in Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology. Despite its current Q4 quartile ranking in these categories, the journal aspires to extend its influence and visibility in the academic community, aiming for greater impact in the future. The journal features research articles that span a wide array of topics in biotechnology, fostering a collaborative and knowledge-rich environment for national and international scholars. We invite you to explore, contribute to, and engage with the expanding landscape of biotechnological research through the Research Journal of Biotechnology.

Computational and Structural Biotechnology Journal is a premier open-access journal published by Elsevier, focusing on the intersection of computer science and molecular biology. Since its inception in 2012, the journal has established itself as a leading platform for innovative research, featuring groundbreaking studies in biochemistry, biophysics, biotechnology, and genetics. With a remarkable Q1 ranking in multiple categories, including Biochemistry and Genetics, it stands out for its high impact, evidenced by its strong Scopus ranking percentile scores. As a vital resource for researchers, professionals, and students, the journal aims to foster the dissemination of essential findings that leverage computational techniques to explore complex biological systems. In a rapidly evolving scientific landscape, Computational and Structural Biotechnology Journal serves as an indispensable resource for those looking to contribute and stay abreast of major advancements in the field.

Minerva Biotechnology and Biomolecular Research is an emerging journal published by EDIZIONI MINERVA MEDICA, dedicated to the fields of biotechnology, biomolecular research, and applied microbiology. With an ISSN of 2724-542X and an E-ISSN of 2724-5934, this journal aims to foster deeper understanding and innovative advancements in these rapidly evolving disciplines. The journal has been categorized in the Q4 quartile across four categories in the 2023 rankings, highlighting its nascent yet growing influence within the scientific community. Operating on an open-access model, it enhances accessibility and encourages the dissemination of knowledge to researchers, professionals, and students alike. Set in the heart of Italy, specifically at CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY, Minerva Biotechnology and Biomolecular Research will continue to enrich the scientific literature from its inception in 2021 through 2024 and beyond, contributing to the global dialogue on biotechnological innovations and molecular research.

TRENDS IN BIOTECHNOLOGY, published by CELL PRESS, stands as a premier journal since its inception in 1983, focusing on the dynamic and ever-evolving fields of bioengineering and biotechnology. With a notable impact factor and ranking in the top quartile (Q1) of its categories for 2023, this journal is recognized for its contribution to advancing scientific knowledge, boasting a Scopus rank of #5/311 in Biotechnology and #5/162 in Bioengineering, placing it in the 98th and 97th percentiles, respectively. Although it does not operate under an open access model, TRENDS IN BIOTECHNOLOGY ensures a rigorous peer-review process that provides a platform for high-quality research that influences both academic and industrial advancements. The journal's objectives encompass the dissemination of cutting-edge research findings, reviews, and insights that foster innovation in biotechnological applications, making it an invaluable resource for researchers, professionals, and students alike. With its broad scope across the intersection of biosciences and technology, TRENDS IN BIOTECHNOLOGY continues to lead discussions and developments that shape the future of the biotechnology landscape.

Biotechnology and Genetic Engineering Reviews is a prominent journal published by Taylor & Francis Ltd, specializing in the rapidly evolving fields of biotechnology and genetic engineering. Since its inception in 1984, this journal has served as a critical platform for researchers and professionals to disseminate groundbreaking scientific findings, review methodologies, and discuss emerging trends within the domain. With a substantial track record of convergence in its publication history from various years, it currently holds Q2 rankings in both Bioengineering and Biotechnology, alongside a Q3 ranking in Molecular Biology for 2023. Its dedication to quality research is reflected in its Scopus rankings, which position the journal favorably within the competitive landscape of biochemistry and molecular biology. Although it is not an open-access journal, Biotechnology and Genetic Engineering Reviews remains committed to providing accessible insights to the global scientific community, making it an invaluable resource for students, academics, and industry professionals keen on advancing their knowledge in these crucial fields.

New Biotechnology, published by Elsevier, is a distinguished academic journal focused on the innovative realms of biotechnology and bioengineering. With an impact factor reflecting its strong presence in the field, this journal serves as a vital resource for researchers and professionals in the life sciences, offering insights into cutting-edge advancements and applications in biotechnology, molecular biology, and related disciplines. The journal's open access policy enhances its accessibility, allowing broad dissemination of knowledge and research findings. With a robust set of Scopus ranks placing it in the top tiers of its categories, including rank #36 in Biotechnology and #24 in Bioengineering, New Biotechnology represents a critical platform for scholars aiming to contribute to the ongoing dialogue in these rapidly evolving fields. Since its inception in 2008 and continuing through to 2024, the journal remains committed to fostering innovation and collaboration among scientists dedicated to advancing biotechnological applications, thereby significantly impacting medicine and industry.

Journal of Genetic Engineering and Biotechnology, published by Elsevier Science Inc, is a prestigious open-access journal that stands at the forefront of research in the fields of biotechnology and genetics. Since its inception in 2011, the journal has provided a platform for cutting-edge studies that explore the complexities and innovations within genetic engineering and its applications in biotechnology. With a commendable Impact Factor and recognized as a Q2 journal in both biotechnology and genetics as per 2023 categorization, it ranks well within Scopus, evidencing its influence in the scientific community. Researchers and professionals accessing articles published in this journal benefit from timely contributions that bridge theoretical and practical aspects of genetic technologies. By fostering a collaborative environment, the Journal of Genetic Engineering and Biotechnology aims to promote advancements that drive science forward, making it an essential resource for students, academics, and industry practitioners alike. For those interested in making their mark in these rapidly evolving fields, this journal offers unparalleled access to high-quality, peer-reviewed research.

BioTech is a forward-thinking academic journal published by MDPI, specializing in the dynamic fields of applied microbiology, biotechnology, biochemistry, bioengineering, and biomedical engineering. Established for promoting impactful research from 2021 to 2024, this journal aims to bridge the gap between laboratory findings and practical applications, serving as a vital resource for researchers, practitioners, and students alike. With its Open Access model, BioTech ensures that groundbreaking innovations are freely available to the global community, fostering collaboration and knowledge transfer across disciplines. In the 2023 rankings, BioTech holds a strong position in Q2 and Q3 quartiles across various categories, reflecting its commitment to high-quality research output. Being indexed in renowned databases, the journal enhances its visibility and reach, making it a preferred platform for sharing transformative ideas and discoveries in biotechnology and related domains. Set against the backdrop of Switzerland’s thriving research environment, BioTech is poised to become an essential resource in the rapidly evolving landscape of life sciences.

Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.